|
中華人民共和國國家衛生健康委員會,2014。食品安全國家標準,食品添加劑使用標準。GB 2760-2014版本。 行政院衛生署食品藥物管理局,2011。2010-2011臺灣營養健康狀況變遷調查:國中生調查。 行政院衛生署食品藥物管理局,2011。2011臺灣營養健康狀況變遷調查:高中生調查。 行政院衛生福利部,2018。食品安全衛生管理法。2018年01月24日,總統華總一義字第10700007751號令修正公布。 行政院衛生福利部食品藥物管理署(TFDA),2016。健康風險評估資料專區,磷酸(phosphoric acid)。 行政院衛生福利部食品藥物管理署(TFDA),2016。國人攝食磷酸鹽類之總膳食調查與風險評估。 行政院衛生福利部食品藥物管理署(TFDA),2017。臺灣食品成分資料庫2017版。2018年6月12日,取自:https://consumer.fda.gov.tw/Food/TFND.aspx?nodeID=178。 行政院衛生福利部食品藥物管理署(TFDA),2018。包裝食品營養標示應遵行事項。2018年03月31日,衛授食字第1071300530 號修正公告。 行政院衛生福利部食品藥物管理署(TFDA),2018。食品添加物使用範圍及限量標準。2018年01月09日,衛生福利部衛授食字第1061303630號修正發布。 行政院衛生福利部國民健康署,2008。2007年臺灣地區高血壓、高血糖、高血脂追蹤調查研究。2018年06月11日,取自:http://www.bhp.doh.gov.tw/bhpnet/portal/file/ThemeDocFile/2011 02140310199776/2007三高專輯_簡單版 _20110729.pdf。 行政院衛生福利部國民健康署,2011。國人膳食營養素參考攝取量修訂第七版。2018年06月11日,取自:https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=544&pid=725。 行政院衛生福利部國民健康署,2014。慢性腎臟病患者健康管理手冊。2018年06月11日,取自:https://www.hpa.gov.tw/Pages/EBook.aspx?nodeid=1157。 行政院衛生福利部國民健康署慢性疾病防治組,2010。臺灣洗腎人口多的原因。2018年06月11日,取自:https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=635&pid=1200。 行政院衛生福利部統計處,2018。民國105年死因統計年報電子書。2018年06月11日,取自:https://dep.mohw.gov.tw/DOS/lp-3352-113.html。 吳幸娟,章雅惠,張新儀,潘文涵,2001。臺灣地區成人攝入礦物質(鈣、磷、鐵、鈉)之食物來源:1993-1996國民營養健康狀況變遷調查結果。臺灣營養學會雜誌,26(3),142-158。 吳幸娟,潘文涵,葉乃華,張新儀,2013。臺灣國小學童營養健康狀況調查 2001-2002,以24小時飲食回顧法評估國小學童膳食營養狀況。2018年06月11日,取自:https://www.fda.gov.tw/tc/siteList.aspx?sid=279。 林裕峯,2015。慢性腎臟病世代追蹤研究(101-104年),104年度後續擴充計畫。行政院衛生福利部國民健康署,計畫編號:MOHW104-HPA-H-114-134101。 厚生労働省,2017。食品添加物リスト,添加物使用基準リスト。平成28年9月26日改正まで記載。 厚生労働省。2013。平成25年度マーケットバスケット方式による酸化防止剤、防かび剤等の摂取量調査の結果について。 黃俊達,2017。臺灣民眾攝取磷酸鹽類之總膳食研究。國立臺灣海洋大學食品科學系碩士論文。 黃登福,陳陸宏,謝承紘,葉彥宏,黃培安,劉建功,林苑暉,葉佳聖,林旺熠,康藏文,王惠珠,郭嘉信,李菁菁,游銅錫,陳榮輝,張永鍾,邱文貴,周薰修,曹欽玉,2015。實用食品添加物,第四版。 趙昆華,景洪崗,孫國慶,2003。中國食品添加劑,第z1期,磷酸鹽在食品加工中的應用。 潘文涵,2005、2010、2011、及2012。2005-2008、2010、2011、及2012年度國民營養健康狀況變遷調查(NAHSIT)。行政院衛生署2012年度委託計畫。 Australian Government, 2016. Australia New Zealand Food Standards Code, Standard 1.3.1 Food Additives. Chang AR, Lazo M, Appel LJ, Gutierrez OM, Grams ME, 2014. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. The American Journal of Clinical Nutrition. 99: 320-327. Chartsrisak K, Vipattawat K, Assanatham M, Nongnuch A, Ingsathit A, Domrongkitchaiporn S, Sumethkul V, Distha-Banchong S, 2013. Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients. BMC Nephrology, 14: 14. Codex Alimentarius Commission (CODEX or CAC). 2013. Procedural manual. Codex Committee on Food Additives and Contaminants (CCFAC) guidelines for exposure assessment of contaminants and toxins in food or food groups. 15th ed. Craig JM, 1957. Histologic and histochemical changes in the kidney of rats fed a diet with an excess od inorganic phosphate. American Journal of Pathology, 33: 621. Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E, 2007. Mineral metabolism parameters throughout chronic kidney disease stages 1–5: Achievement of K/DOQI target ranges. Nephrology Dialysis Transplantation. 22: 1171-1176. Collins AJ. United States Renal Data System (USRDS), 2014. Annual data report: epidemiology of kidney disease in the United States. Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, Lv J, Zhang L, Wang H, 2015. Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases. 66(2): 258-265. de Boer IH, Rue TC, Kestenbaum B, 2009. Serum Phosphorus Concentrations in the Third National Health and Nutrition Examination Survey (NHANES III). American Journal of Kidney Diseases. 53(3): 399-407. Di Bartola SP, 2012. Fluid, electrolyte, and acid-base disorders in small animal practice, 4th Ed. Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, O'Donoghue DJ, Middleton RJ, Kalra PA, 2010. Serum phosphate and mortality in patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology. 5(12): 2251-2257. Egan SK, Tao SSH, Pennington JAT, Bolger PM, 2002. US Food and Drug Administration's Total Diet Study: intake of nutritional and toxic elements, 1991-96. Food Additives & Contaminants, 19(2): 103-125. Ellinger RH, 1972. Phosphates as food ingredients. Cleveland, Ohio, CRC Press. 19-25. European Food Safety Authority (EFSA), 2011. Commission regulation (Eu) No 1130/2011 of 11 November 2011. European Food Safety Authority (EFSA), 2015. Scientific Opinion on Dietary Reference Values for phosphorus. EFSA Journal, 13(7): 4185. European Food Safety Authority/World Health Organization/Food and Agriculture Organization (EFSA/WHO/FAO), 2011. Towards a harmonized total diet study approach: a guidance document. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P, 2007. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. Journal of the American Society of Nephrology. 18(9): 2600-2608. Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N, 1980. Renal toxicity of phosphate in rats. Kidney International, 17(6): 722-731. Ix JH, Anderson CA, Smits G, Persky MS, Block GA, 2014. Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study. The American Journal of Clinical Nutrition. 100: 1392-1397. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL, 2005. Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease. Journal of the American Society of Nephrology, 16(2): 520-528. Kidney Disease: Improving Global Outcomes (KDIGO), 2012. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. NGC: 009925. Korea Ministry of Food and Drug Safety Safe Food & Drugs, Healthy People Happy Society, 2016. Food Additives Code, 16.11.16. Korea National Health and Nutrition Examination Survey, 2015. 2018/06/11. From: https://knhanes.cdc.go.kr/knhanes/eng/index.do Kovesdy CP, Anderson JE, Kalantar-Zadeh K, 2010. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clinical Nephrology, 73(4): 268-275. Mehrotra R, Peralta CA, Chen SC, Li S, Sachs M, Shah A, Norris K, Saab G, Whaley-Connell A, Kestenbaum B, McCullough PA; Kidney Early Evaluation Program (KEEP) Investigators, 2013. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney International. 84(5): 989-97. Moore LW, Nolte JV, Gaber AO, Suki WN, 2015. Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. The American Journal of Clinical Nutrition. 102: 444-453. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD, 2010a. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clinical Journal of the American Society of Nephrology. 5(4): 683-692. Noori N, Sims JJ, Kopple JD, Shah A, Colman S, Shinaberger CS, Bross R, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K, 2010b. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iranian Journal of Kidney Diseases. 4(2): 89-100. O'Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS, 2011. Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrology Dialysis Transplantation, 26(9): 2885-2890. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR, Rhee EJ, Oh KW, Lee WY, Park CY, Park SW, Kim SW, 2009. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: A double-edged sword. Diabetes Research and Clinical Practice. 83: 119-125. Portale AA, Halloran BP, Morris RC, 1987. Implications for the renal production of 1,25-dihydroxyvitamin D. Journal of Clinical Investigation. 80: 1147-1154. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL, 2016. Factors aff ecting outcomes in patients reaching end-stage kidney disease worldwide: diff erences in access to renal replacement therapy, modality use, and haemodialysis practices. The Lancet, 388(No. 10041): 294-306. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP, 2006. Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 1(4): 825-831. Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M, 2013. Mineral metabolites and CKD progression in African Americans. Journal of the American Society of Nephrology. 24: 125-135. Selamet U, Tighiouart H, Sarnak MJ, Beck G, Levey AS, Block G, Ix JH, 2016. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study. Kidney International. 89(1): 176-184. Sim JJ, Bhandari SK, Smith N, Chung J, Liu IL, Jacobsen SJ, Kalantar-Zadeh K, 2013. Phosphorus and risk of renal failure in subjects with normal renal function. American Journal of Medicine. 126(4): 311-318. Smith DH, Johnson1 ES, Thorp ML, Petrik A, Yang X, Blough DK, 2010. Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study. Nephrology Dialysis Transplantation, 20: 166-174. The Joint FAO/WHO Experts Committee on Food Additives (JECFA), 1970. Phosphoric acid and phosphate salts. The Joint FAO/WHO Experts Committee on Food Additives (JECFA), 1982. Toxicological evaluation of some extretion solvents and certain other substances. United States Environmental Protection Agency (USEPA), 1998. Guidelines for Ecological Risk Assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. United States Food and Drug Administration (USFDA), Select Committee on GRAS Substances (SCOGS), 1975. Opinion: Phosphates. Uribarri J, Calvo MS, 2003. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Seminars in Dialysis. 16: 186-188. Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D, 2017. The role of phosphate in kidney disease. Nature Reviews Nephrology. 13: 27-38. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF, 2008. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. The Lancet, 371(9631): 2173-2182. Wu MJ, Shu KH, Liu PH, Chiang PH, Cheng CH, Chen CH, Yu DM, Chuang YW, 2010. High risk of renal failure in stage 3B chronic kidney disease is under-recognized in standard medical screening. Journal of the Chinese Medical Association, 73(10): 515-522. Young VR, Erdman JW, King JC, Allen LH, Atkinson SA, Dwyer JT, Fernstrom JD, Grundy SM, Hennekens CH, Miller SA, Meyers L, Fischer PWF, Yates AA, Kennedo G, Spears GE, 1998. Institute of Medicine (US) Food and Nutrition Board. Washington (DC): National Academies Press (US). Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients. Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Mallamaci F, Remuzzi G, the REIN Study Group, 2011. Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition. Journal of the American Society of Nephrology, 22(10): 1923-1930.
|